<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medbio</journal-id><journal-title-group><journal-title xml:lang="ru">Медико-биологические проблемы жизнедеятельности</journal-title><trans-title-group xml:lang="en"><trans-title>Medical and Biological Problems of Life Activity</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2088</issn><publisher><publisher-name>Республиканский научно-практический центр радиационной медицины и экологии человека</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medbio-237</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Цитокиновый профиль реципиентов почечного трансплантата в раннем послеоперационном периоде</article-title><trans-title-group xml:lang="en"><trans-title>Cytokine profile in kidney transplant recipients in the early postoperative period</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыблев</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyblev</surname><given-names>S. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыблева</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zybleva</surname><given-names>S. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коротаева</surname><given-names>Л. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Korotaeva</surname><given-names>L. .</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ «РНПЦ радиационной медицины и экологии человека»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>02</day><month>03</month><year>2023</year></pub-date><volume>0</volume><issue>2</issue><fpage>105</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зыблев С.Л., Зыблева С.В., Коротаева Л.Е., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Зыблев С.Л., Зыблева С.В., Коротаева Л.Е.</copyright-holder><copyright-holder xml:lang="en">Zyblev S..., Zybleva S..., Korotaeva L...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medbio.ejournal.by/jour/article/view/237">https://medbio.ejournal.by/jour/article/view/237</self-uri><abstract><p>Проведен сравнительный анализ содержания цитокинов в периферической крови 41 пациента с хронической болезнью почек, которым выполнена трансплантация почки в ГУ «РНПЦ РМиЭЧ». Определяли уровень интерлейкина 2, 1β, 6, 8 до трансплантации, через 24 часа и через 3-е суток после трансплантации. Выявлен значимый рост уровня ИЛ-2 уже через 24 часа после операции с некоторым снижением к 3-м суткам, однако показатель оставался выше относительно концентрации в группе сравнения. Отмечен значимый рост уровня ИЛ-6 по сравнению с контролем уже через 24 часа после пересадки почки, высокий показатель которого сохранялся на протяжении 3-х суток, несмотря на некоторое снижение. Не было выявлено значимых различий показателей уровня ИЛ-1β у реципиентов почечного трансплантата по сравнению с группой сравнения и в первые трое суток послеоперационного периода. Однако отмечен рост концентрации данного цитокина к 3-м суткам после трансплантации. Значимое преобладание уровня ИЛ-8 у реципиентов по сравнению с контролем выявлено только в первые сутки послеоперационного периода. Изучение профиля ИЛ-1β, 2, 6, 8 и факторов, влияющих на их концентрацию, у реципиентов почечного трансплантата в раннем послеоперационном периоде является перспективным для определения новых возможностей для специфической терапии с целью улучшения результатов почечной аллотрансплантации.</p></abstract><trans-abstract xml:lang="en"><p>We have carried out a comparative analysis of the cytokine contentl in the peripheral blood of 41 patients with chronic kidney disease who underwent kidney transplantation at the RRCRM&amp;HE. The level of interleukin 2, 1β, 6, 8 was determined before transplantation, 24 hours later and 3 days after transplantation. A significant increase in the IL-2 level was revealed already 24 hours after the transplantation with a slight decrease by the 3rd day, however, the indicator remained higher relative to the concentration in the control group. There was a significant increase in the IL-6 level in comparison with the control group already 24 hours after kidney transplantation, a high level of which persisted for 3 days, despite a slight decrease. There were no significant differences in relation to the IL-1β level in renal transplant recipients in comparison with the control group in the first three days of the postoperative period. However, an increase in the concentration of this cytokine was noted by the 3rd day after transplantation. A significant predominance of the IL-8 level in recipients compared with control groups was revealed only on the first day of the postoperative period. The study of the IL-1β, 2, 6, 8 profile and factors affecting their concentration in renal transplant recipients in the early postoperative period is promising for determining new possibilities for specific therapy in order to improve the results of renal allograft transplantation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ИЛ-1β</kwd><kwd>ИЛ-2</kwd><kwd>ИЛ-6</kwd><kwd>ИЛ-8</kwd><kwd>трансплантация почки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>IL-1β</kwd><kwd>IL-2</kwd><kwd>IL-6</kwd><kwd>IL-8</kwd><kwd>kidney transplantation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Morris, P. J. Kidney transplantation: principles and practic / P. J. Morris, S. J. Knechtle; edited by P. J. Morris, S. J. Knechtle. - 6th ed. Philadelphia: Saunders Elsevier, 2013. - 880 p.</mixed-citation><mixed-citation xml:lang="en">Morris, P. J. Kidney transplantation: principles and practic / P. J. Morris, S. J. Knechtle; edited by P. J. Morris, S. J. Knechtle. - 6th ed. Philadelphia: Saunders Elsevier, 2013. - 880 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Influence of Innate Immunity on Immune Tolerance / U. C. Kucuksezer [et al.] // Acta medica academica. - 2020. - № 49. - P. 164-180.</mixed-citation><mixed-citation xml:lang="en">Influence of Innate Immunity on Immune Tolerance / U. C. Kucuksezer [et al.] // Acta medica academica. - 2020. - № 49. - P. 164-180.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cytokines affecting CD4+T regulatory cells in transplant tolerance. II.Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+T regulatory cells / M. Nomura [et al.] // Transpl Immunol. - 2017. - №42. - P. 24-33.</mixed-citation><mixed-citation xml:lang="en">Cytokines affecting CD4+T regulatory cells in transplant tolerance. II.Interferon gamma (IFN-γ) promotes survival of alloantigen-specific CD4+T regulatory cells / M. Nomura [et al.] // Transpl Immunol. - 2017. - №42. - P. 24-33.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Paunicka, K. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells / K. Paunicka, P. W. Chen, J. Y. Niederkorn // J Leukoc Biol. - 2012. - Vol. 91, №3. - P. 475-483.</mixed-citation><mixed-citation xml:lang="en">Paunicka, K. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells / K. Paunicka, P. W. Chen, J. Y. Niederkorn // J Leukoc Biol. - 2012. - Vol. 91, №3. - P. 475-483.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Prolonged islet allograft acceptance in the absence of interleukin 4 expression / P. Nickerson [et al.] // Transplant Immunol. - 1996. - №4. - P. 81-85.</mixed-citation><mixed-citation xml:lang="en">Prolonged islet allograft acceptance in the absence of interleukin 4 expression / P. Nickerson [et al.] // Transplant Immunol. - 1996. - №4. - P. 81-85.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance / S. Sakaguchi // Cell. - 2000. - № 101. - P. 455-458.</mixed-citation><mixed-citation xml:lang="en">Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance / S. Sakaguchi // Cell. - 2000. - № 101. - P. 455-458.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stenken, J. A. Bioanalytical chemistry of cytokines-A review /j. A. Stenken, A. J. Poschenrieder //Analytica chimica acta. - 2015. - Vol. 853. - Р. 95-115.</mixed-citation><mixed-citation xml:lang="en">Stenken, J. A. Bioanalytical chemistry of cytokines-A review /j. A. Stenken, A. J. Poschenrieder //Analytica chimica acta. - 2015. - Vol. 853. - Р. 95-115.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Профиль интерлейкина-6 в раннем послеоперационном периоде после трансплантации почки / А.В. Ватазин [и др.] // Вестник трансплантологии и искусственных органов. - 2013. - Т. 15, №1. - С. 51-59.</mixed-citation><mixed-citation xml:lang="en">Профиль интерлейкина-6 в раннем послеоперационном периоде после трансплантации почки / А.В. Ватазин [и др.] // Вестник трансплантологии и искусственных органов. - 2013. - Т. 15, №1. - С. 51-59.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Телетаева, Г.М. Цитокины и противоопухолевый иммунитет / Г. М. Телетаева // Практическая онкология. - 2007. - Т. 8, №4. - С. 211-218.</mixed-citation><mixed-citation xml:lang="en">Телетаева, Г.М. Цитокины и противоопухолевый иммунитет / Г. М. Телетаева // Практическая онкология. - 2007. - Т. 8, №4. - С. 211-218.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Uciechowski, P.Interleukin-6: a masterplayer in the cytokine network / P. Uciechowski, W.C.M. Dempke // Oncology. - 2020. - Vol. 98, №3. - P.131-137.</mixed-citation><mixed-citation xml:lang="en">Uciechowski, P.Interleukin-6: a masterplayer in the cytokine network / P. Uciechowski, W.C.M. Dempke // Oncology. - 2020. - Vol. 98, №3. - P.131-137.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature / C.M. Mulders-Manders [et al.] //Front Pharmacol. - 2017. - Vol. 31, №8. - P. 342.</mixed-citation><mixed-citation xml:lang="en">Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature / C.M. Mulders-Manders [et al.] //Front Pharmacol. - 2017. - Vol. 31, №8. - P. 342.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu, B. Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets / B. Liu, J. Li, L.N. Yan // Clinical and Developmental Immunology. - 2013. - Vol. 2013. - P. 1-15.</mixed-citation><mixed-citation xml:lang="en">Liu, B. Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets / B. Liu, J. Li, L.N. Yan // Clinical and Developmental Immunology. - 2013. - Vol. 2013. - P. 1-15.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Belperio, J.A. Chemokines and transplant vasculopathy /j.A. Belperio, A. Ardehali // Circ Res. - 2008. - Vol. 103, №5. - Р. 454-466.</mixed-citation><mixed-citation xml:lang="en">Belperio, J.A. Chemokines and transplant vasculopathy /j.A. Belperio, A. Ardehali // Circ Res. - 2008. - Vol. 103, №5. - Р. 454-466.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cravedi, P. Immunologic monitoring in transplantation revisited / P. Cravedi, P.S. Heeger // Current opinion in organ transplantation. - 2012. - Vol. 17, №1. - Р. 26.</mixed-citation><mixed-citation xml:lang="en">Cravedi, P. Immunologic monitoring in transplantation revisited / P. Cravedi, P.S. Heeger // Current opinion in organ transplantation. - 2012. - Vol. 17, №1. - Р. 26.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cytokines signatures in short and long-term stable renal transplanted patients / A.P. Mota [et al.] // Cytokine. - 2013. - Vol. 62, №2. - P. 302-309.</mixed-citation><mixed-citation xml:lang="en">Cytokines signatures in short and long-term stable renal transplanted patients / A.P. Mota [et al.] // Cytokine. - 2013. - Vol. 62, №2. - P. 302-309.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Interleukin 8 Is Overexpressed in Acute Rejection in Kidney Transplant Patients / L. García-Covarrubias [et al.] // Transplant Proc. - 2020. - Vol. 52, №4. - P. 1127-1131.</mixed-citation><mixed-citation xml:lang="en">Interleukin 8 Is Overexpressed in Acute Rejection in Kidney Transplant Patients / L. García-Covarrubias [et al.] // Transplant Proc. - 2020. - Vol. 52, №4. - P. 1127-1131.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
